Article | Open | Published:

A new role for Zinc limitation in bacterial pathogenicity: modulation of α-hemolysin from uropathogenic Escherichia coli

Scientific Reportsvolume 8, Article number: 6535 (2018) | Download Citation


Metal limitation is a common situation during infection and can have profound effects on the pathogen’s success. In this report, we examine the role of zinc limitation in the expression of a virulence factor in uropathogenic Escherichia coli. The pyelonephritis isolate J96 carries two hlyCABD operons that encode the RTX toxin α-hemolysin. While the coding regions of both operons are largely conserved, the upstream sequences, including the promoters, are unrelated. We show here that the two hlyCABD operons are differently regulated. The hly II operon is efficiently silenced in the presence of zinc and highly expressed when zinc is limited. In contrast, the hly I operon does not respond to zinc limitation. Genetic studies reveal that zinc-responsive regulation of the hly II operon is controlled by the Zur metalloregulatory protein. A Zur binding site was identified in the promoter sequence of the hly II operon, and we observe direct binding of Zur to this promoter region. Moreover, we find that Zur regulation of the hly II operon modulates the ability of E. coli J96 to induce a cytotoxic response in host cell lines in culture. Our report constitutes the first description of the involvement of the zinc-sensing protein Zur in directly modulating the expression of a virulence factor in bacteria.


During infection, pathogens often encounter metal limitation. Alterations in the concentrations of certain metal ions have a great impact in cell physiology and gene expression. For instance, changes in the concentration of iron regulate the expression of virulence factors through metalloregulatory proteins such as Fur, the ferric uptake regulator, and the closely related PerR, the peroxide-stress regulator1,2. Recent studies revealed that another metal ion, zinc, also has an effect on bacterial physiology during infection3,4. Zinc is an essential element as a catalytic or structural cofactor of key enzymes and proteins involved in many processes such as DNA replication and protein synthesis and turnover5,6. Conversely, zinc can be toxic to bacteria when present in excess and so intracellular levels must be tightly controlled5,7. Zinc release from host tissue has been proposed to be an important innate defense mechanism7. In the case of S. pneumoniae infection in mice, elevated total zinc concentrations have been reported in host tissue and serum samples. The authors propose that the ability of zinc excess to inhibit pathogen growth arises from zinc competition with Mn uptake7. Zinc concentration in host fluids can rise in response to bacterial infection and inflammation by its release from damaged or apoptotic cells, and from sequestering proteins such as metallothionein7.

Studies in both E. coli and B. subtilis have shown that, in response to variations in zinc concentration, cells regulate gene expression using the metalloregulatory protein Zur (zinc uptake regulator) as a sensor. Zur forms a dimeric complex with zinc acquiring the ability to bind DNA and to repress gene expression8. Characterized Zur regulons mainly consist of genes coding for proteins involved in zinc homeostasis and paralogs of ribosomal proteins which, under zinc limitation conditions, replace ribosomal proteins that contain zinc9. Although most known Zur-regulated genes are involved in zinc uptake and adaptation to low concentrations of the metal8,9,10, a number of questions about how Zur impacts overall cell physiology and pathogenesis remain unanswered.

Uropathogenic Escherichia coli (UPEC) is the main causal agent of community-acquired urinary tract infections. In order to colonize its host, it expresses a battery of virulence factors including adhesins, siderophores, flagella, and toxins11. One of these factors is the pore-forming toxin α-hemolysin, whose expression induces tissue damage and more severe infections12. Approximately 40–50% of UPEC isolates are able to produce α-hemolysin13. Remarkably, a recent study in mice linked zinc concentrations to the pathogenic effect of α-hemolysin during gastrointestinal disorders, showing that treatment with zinc protects against α-hemolysin-induced intestinal barrier disfunction14.

α-hemolysin is encoded in the polycistronic operon hlyCABD, which contains four open reading frames (ORFs)15. The hlyC gene codes for an acyltransferase required for the activation of pro-α-hemolysin. Pro-α-hemolysin is encoded by hlyA, while the hlyB and hlyD genes encode two components of the secretory system that transports α-hemolysin out of the cells16,17. The hlyCABD operon in E. coli is tightly regulated and strongly affected by several environmental and physiological signals. A number of regulators, including RfaH, CpxRA and H-NS, modulate α-hemolysin expression18,19,20,21. In hemolytic UPEC isolates from humans, the hlyCABD operon is present in the chromosome within pathogenicity islands, together with genes coding for other virulence factors22,23. Although most hemolytic UPEC strains carry a single copy of the operon, the presence of two functional copies of the hlyCABD operon has been detected in two pyelonephritis isolates, J96 and 53623.

In this article, we show that the two hemolytic operons present in the chromosome of E. coli J96 are differentially regulated. The hly I operon does not respond to zinc limiting conditions whereas the hly II operon is silenced in the presence of zinc in a Zur-dependent manner. A highly conserved Zur binding site was found in the promoter sequence of the hly II operon. Direct binding of Zur to this promoter was confirmed by electrophoretic mobility shift assay (EMSA). Although a role of Zur-mediated regulation in bacterial pathogenicity has previously been suggested6,24, our research represents the first description of the involvement of zinc and the zinc-sensing transcription factor Zur in regulating the expression of a virulence factor in bacteria directly.


The two hemolytic operons of J96 are differentially expressed

Two UPEC isolates, J96 and 536, extensively used as model organisms in pathogenicity studies, have two functional hlyCABD operons (designated I and II) coding for α-hemolysin (HlyA)23. The full sequences of the two operons from 536 and the hlyCABD II operon (hly II ) from J96 are known; however, only a fragment of the hlyCABD I operon (hly I ) from J96, carrying part of the hlyC gene (224 bp) and its upstream sequence, is available. While the ORFs of the sequenced operons are almost identical, the hlyC upstream sequences carrying the promoter and the regulatory motifs diverge extensively between operons (Fig. 1a). Consistent with a previous report23, pairwise alignments showed two different types of sequence upstream of hlyC and indicated that the hlyII-J96 operon is identical to the hlyI-536 operon and that hlyI-J96 is identical to hlyII-536. The hlyII-J96 operon was the first hlyCABD operon cloned from human isolates and used to substantiate the contribution of HlyA to UPEC virulence25,26.

Figure 1
Figure 1

Differential expression of the two hlyCABD operons present in the J96 strain. (a) Percentage of identity at the level of the nucleotide sequence between the operon hly I and hly II of J96 and 536. n.d.: not determined. (b) Hemolytic phenotype of J96, JFV16 (J96ΔII) and JFV21 (J96ΔI) strains on Columbia Blood agar plates. (c) Coomassie blue stained SDS-PAGE (10%) of secreted protein extracts from cultures grown in LB0 at 37 °C up to late-log phase (OD600 nm of 1.0) of the indicated strains. Lane M: molecular mass markers (size in kDa indicated along the left side). The band corresponding to α-hemolysin (HlyA) is indicated with an arrowhead. Full-length gel image is shown in Fig. S6.

J96 derivative mutant strains carrying partial deletions of either hly I or hly II were obtained by gene replacement. The hemolytic phenotype of the mutant derivatives was monitored on Columbia Blood Agar (CBA) plates (Fig. 1b). The mutant J96ΔII (Δhly II ), carrying only the hly I operon, displays a phenotype identical to the J96 strain. However, the J96ΔI (Δhly I ), carrying only the hly II operon, exhibits a very thin hemolytic halo, suggesting that very little HlyA is produced from hly II operon under optimal conditions for HlyA detection27. The levels of secreted HlyA by J96 and its derivatives J96ΔI and J96ΔII were determined in bacterial cultures grown in LB0 (with no NaCl added) at 37 °C up to late-logarithmic phase. SDS-PAGE separation of secreted protein extracts from J96 revealed a single band at 110 kDa, corresponding to HlyA. Consistent with the hemolytic phenotype, the amount of HlyA secreted by the J96ΔII strain (hly I operon) was very similar to the amount detected in the extract from the wild-type strain, whereas the amount of HlyA secreted by the J96ΔI strain (hly II operon) was much lower (Fig. 1c). These results suggest that in the assessed experimental conditions, the hly I operon is the main contributor to the HlyA production and the hly II operon is somehow silenced. The extracts analyzed in Fig. 1c were obtained from cultures grown in LB0, however, the described differential expression of the two hly operons of J96 does not depend on the external osmolarity. Secreted protein extracts from cultures grown in LB (5 g l−1 of NaCl) were also analyzed. Although expression of HlyA was lower in all the strains, hly I expressed most of the HlyA, while expression of HlyA from the hly II operon was barely detected (Fig. S1).

A mutation in zur, encoding the zinc uptake regulator, causes derepression of the hly II operon

To identify putative regulators of the hly II operon responsible for its low expression under the assessed conditions, random mutagenesis using a gentamycin resistance mariner transposon was performed on strain JFV3, a J96 derivative that carries a chromosomal hly II ::lacZ reporter fusion. Mutants were selected according to their Lac phenotype on LB agar plates with X-gal, to detect hly II ::lacZ expression. The clone #13 was selected for its deep blue colour compared to the parental strain, which indicates increased expression of hly II ::lacZ (Fig. 2a). Quantitative expression studies showed that the selected GmR mutant causes a drastic derepression (47-fold) of the hly II operon transcriptional expression (Fig. 2b). Using primers for the mariner transposon, the nucleotide sequence adjacent to the insertion was determined in clone #13. The transposon was inserted within the zur gene, in codon 142 of 172.

Figure 2
Figure 2

Expression of the hly II operon of J96 is derepressed by a mutation in the zur gene. (a) Lac-phenotype on LB Xgal agar plates of the JFV3 (J96 hly II ::lacZ) strain and its GmR derivative (clone #13) obtained by random mutagenesis. Below is represented the location of the GmR transposon insertion in clone #13. (b) Transcriptional expression of the hly II operon from cultures of the JFV3 strain and the two derivatives zur::GmR (clone #13) and zur::CmR (EV46) grown in LB at 37 °C up to late-log phase (OD600 nm of 1.0). β-Galactosidase activity (Miller units) was determined in three independent cultures. Mean values with standard deviations are plotted. *P < 0.05, ANOVA with Tukey’s multiple comparisons test. (c) Electrophoretic analysis of secreted protein extracts from cultures grown in LB at 37 °C up to late-log phase of J96, JFV16 (J96ΔII) and JFV21 (J96ΔI) strains and their otherwise isogenic zur::CmR mutants (EV27, EV34 and EV38, respectively). Upper panels are Coomassie blue stained 10% SDS-PAGE and lower panels immunodetection using monoclonal anti-HlyA antibody. Samples for immunodetection from J96ΔII were concentrated 20x with respect to rest of samples for better visualization. Full-length gel and blot images are shown in Fig. S7. (d) Hemolytic phenotype of JFV16 (J96ΔII) and JFV21 (J96ΔI) strains and its zur mutant derivatives on Columbia Blood agar plates.

The zur gene encodes the Zur protein (zinc uptake regulator), a transcriptional repressor that binds to DNA in the presence of zinc and thereby represses specific genes28. To corroborate the association of Zur with the observed derepression, a new zur mutant was generated in J96 by gene replacement. The sequence of the zur gene between positions 43 and 381 bp (position 1 corresponds to the first nucleotide of the first codon) was deleted, and a CmR cassette was inserted. The zur::CmR allele causes the same effect on hly II transcriptional expression as the GmR allele obtained by random mutagenesis both in late-logarithmic phase (Fig. 2b) and in mid-logarithmic phase (Fig. S2) of bacterial growth. The effect of the zur mutation on hly II expression was also determined by measuring the amount of the secreted HlyA in culture supernatants of Zur proficient and deficient derivatives of J96, J96ΔI and J96ΔII strains. Both Coomassie-staining and immunodetection using specific HlyA antibodies showed a clear increase in the amount of HlyA in the presence of the Δzur mutation in the two strains carrying the hly II operon (J96 and J96ΔI) (Fig. 2c). By contrast, derepression of the hly I operon (J96ΔII strain) was not detected in the zur mutant (Fig. 2c and Fig. S1). Due to the low expression level of the hly I operon in LB, HlyA immunodetection in J96ΔII extracts was performed on 20-fold concentrated samples. Furthermore, the severity of the hemolytic phenotype correlates with the amount of HlyA in each strain. The strain carrying only the operon hly II showed minimal hemolysis in the presence of an intact zur gene and a higher hemolytic phenotype when the zur gene was mutated. Strains carrying only the hly I operon showed the same phenotype, regardless of the presence or absence of an intact zur gene (Fig. 2d). These results clearly indicate that Zur specifically regulates the hly II operon. Zur-mediated regulation of hly II transcription was confirmed by trans-complementation experiments (Fig. 2b). The strong derepression of the hly II operon observed in the zur mutant was fully complemented when a pBR322 derived plasmid containing the J96 zur gene with its own promoter was introduced in the mutant strain. Our findings on the Zur-mediated regulation of the hly II operon of J96 are the first description of a regulatory factor that modulates differently the two hemolytic operons present in J96.

Hemolysin has a role in cell toxicity and urothelial damage during infection19,29. In order to determine the impact of Zur-mediated regulation of α-hemolysin on bacterial pathogenicity, we assessed the ability of different derivatives of the J96 strain to induce hemoglobin release after infection of blood cell suspensions and cell detachment after infection of bladder epithelial cell monolayers. A slight increase in hemolytic activity was detected after infection of the Δzur derivatives of J96 and J96ΔII as compared to the zur+ counterparts (Fig. 3A). Remarkably, the zur mutation caused a very drastic effect when blood cell suspensions were infected with derivatives of the J96ΔI strain. Hemolytic activity was more than 12-fold higher in the Δzur mutant as compared to wild-type strain, consistent with the described derepression of the hly II operon in strains lacking Zur. As a control, J96 derivative strains lacking both hly I and hly II operons showed very low hemolysis in either zur+ or Δzur background. These results clearly demonstrate that the effect observed was caused by α-hemolysin.

Figure 3
Figure 3

Effect of zur mutation in UPEC virulence-associated phenotypes. (A) Hemolysis after 1 hour infection of sheep blood cell suspensions with J96, JFV21 (J96ΔI), JFV16 (J96ΔII) and EV64 (J96ΔIΔII) strains and their otherwise isogenic zur mutants (EV27, EV34, EV38 and EV65). The release of haemoglobin was monitored by OD545 nm. (B) T24 cell monolayer detachment activity. Percentage of remaining attached T24 cells, measured as OD590 nm, after 3.5 h post-infection with the same strains as in (A) Mean values with standard deviation from three independent experiments (A) and three biological replicates (B) are plotted. *P < 0.05 **P < 0.0001 n.s.: non-significant, t test with p-values adjusted by Bonferroni’s method (C) Phase contrast microscopy of T24 bladder epithelial cell monolayers infected for 2 hours with the indicated strains. Scale bar, 0.1 mm.

Next, we performed infection assays of bladder epithelial cells (T24 monolayers) using the same bacterial strains (Fig. 3B). After 3.5 hours of infection with the J96ΔI strain, the monolayers were intact, showing a percentage of attached cells similar to the uninfected monolayers. In contrast, when monolayers were infected with the Δzur derivative of J96ΔI less than 20% of the cells remained attached after 3.5 hours. Again, the effect can be attributed to the production of α-hemolysin since cell attachment did not decrease after infection with J96ΔIΔIIΔzur. The specific effect of α-hemolysin production on cell monolayers could be detected 2 hours post-infection as cells became round-shaped when infected with strain J96ΔIΔzur (Fig. 3C), an α-hemolysin-induced phenotype previously described30. Both wild-type and Δzur derivatives of the J96 and J96ΔII strains, carrying the Zur-independent hly I operon, disrupt cell adhesion at different extents (Fig. 3B). In line with the aforementioned expression studies on the hly II operon, the Δzur mutation triggers virulence-associated features such as hemoglobin release and disruption of epithelial cell adhesion.

Expression of the hly II operon responds to the presence of zinc

In the presence of zinc, the transcriptional regulator Zur forms a complex that binds to DNA, causing transcriptional repression8. We hypothesized that the hly II operon should be repressed by the presence of zinc in a Zur-dependent manner. To test this hypothesis, transcriptional expression of the hly II operon was monitored in cultures of strain JFV3 grown in either LB depleted from zinc (M-LB) or the same medium replenished with 1 μM and 10 μM ZnCl2. In the zur+ strain, hly II transcriptional expression is high in the absence of zinc and severely drops in medium replenished with this metal ion (Fig. 4a). Remarkably, the response of hly II expression to zinc was dose-dependent. Furthermore, zinc-mediated regulation is strictly dependent on the presence of Zur, since no repression is observed in a zur mutant strain by the presence of zinc. The growth kinetics of the JFV3 strain was not altered by the absence or presence of different zinc concentrations (Fig. 4b). The effect of zinc on hly II transcriptional expression was corroborated by monitoring the level of secreted HlyA. In cultures of the strain J96ΔI, a high amount of secreted HlyA was detected in the absence of zinc, whereas the HlyA amount was very low in cultures grown in the presence of ZnCl2 (10 μM) (Fig. 4c). The amount of secreted HlyA from hly I operon was also monitored in both the absence and presence of zinc. Consistent with the fact that hly I operon expression was not altered by the zur mutation, the expression of hly I operon was not affected by the presence of zinc. In cultures of the J96 strain, carrying both hly I and hly II operons, a slight effect on HlyA production by the presence of zinc was detected.

Figure 4
Figure 4

The expression of the hly II operon of J96 responds to the external levels of zinc. (a) Transcriptional expression from the hly II promoter in cultures of the strains JFV3 and its zur::CmR mutant derivative (EV46) grown in M-LB and M-LB replenished with either 1 or 10 μM ZnCl2. Culture samples were taken at late-log growth phase (OD600 nm of 1.0). β-galactosidase activity (expressed in Miller units) was determined from three independent cultures; mean values with standard deviation are plotted. *P < 0.05, ANOVA with Tukey’s multiple comparisons test (b) Growth curves of JFV3 strain cultured in M-LB and in M-LB replenished with 10 μM ZnCl2. Growth was monitored by measuring OD600 nm from two independent cultures; mean values are plotted.(c) Detection of the α-hemolysin in secreted protein extracts from cultures of J96, JFV21 (J96ΔI) and JFV16 (J96ΔII) strains and their otherwise isogenic zur mutants (EV27, EV34 and EV38) grown in M-LB and M-LB replenished with 10 μM ZnCl2. Full-length gel images are shown in Fig. S8.

Zur directly represses hly II expression by binding to its promoter

The effect of sudden addition of ZnCl2 (10 μM) on hly II transcriptional expression was monitored in cultures of strains JFV3 and its ∆zur derivative grown in M-LB medium up to an OD600 nm of 0.3. Bacterial growth was not substantially affected by adding ZnCl2 (10 μM) to the zinc-free medium cultures (Fig. 5a). The ZnCl2 exposure caused a rapid decrease of the hly II transcriptional expression in the Zur proficient strain, as compared to cultures where no ZnCl2 was added (Fig. 5b). After 15 minutes, a drop in hly II expression was already detected, falling to 53% of the levels measured in cultures grown with no ZnCl2 addition. Expression progressively declined to 20% after one hour exposition to ZnCl2. In agreement with all previous results, exposure to ZnCl2 during one hour did not significantly alter the expression of the hly II operon in a zur mutant strain. As a control, the level of hly II operon expression was very low in cultures grown in M-LB replenished with ZnCl2 from the start.

Figure 5
Figure 5

Rapid response of hly II transcriptional expression to zinc addition. (a) Growth curves of the strain JFV3 and EV46 (zur::CmR) in the indicated media by measuring OD600 nm from two independent cultures; mean values are plotted. (b) Transcriptional expression of hly II in cultures of JFV3 and EV46 after zinc addition. Cultures were grown in M-LB up to an OD600 nm of 0.3 when media was either replenished or not with 10 μM ZnCl2. Culture samples were taken right before ZnCl2 addition (0 minutes), and after 15, 30 and 60 minutes. As a control, JFV3 was cultured in M-LB replenished with 10 μM ZnCl2 from the beginning. β-galactosidase activity (expressed in Miller units) was determined from three independent cultures; mean values with standard deviation are plotted.

The fast response to ZnCl2 of hly II transcriptional expression suggested that Zur directly represses the hly II promoter. Zur regulates transcription by cooperative binding of two dimers to a well-characterized DNA sequence located in the vicinity of the promoter of Zur-regulated genes9,31. Using the consensus sequence reported31 for the E. coli Zur box (RNNNYRNNRYNNYRNNNY), the J96 hly II promoter sequence was scrutinized, revealing a putative Zur binding site (Fig. 6a and b). The bases of the Zur box involved in establishing hydrogen-bonds with Zur have been identified31 and are indicated in Fig. 6b. The motif found in the J96 hly II promoter sequence was highly conserved except for the base G19′ (see Fig. S3). It must be noted that G19′ is one of the least determinant bases for Zur binding31.

Figure 6
Figure 6

Zur protein binds to the hly II promoter. (a) Sequence of the hly II operon upstream of hlyC. In bold are indicated the first codon (ATG) of hlyC and the putative −10 and −35 boxes of the promoter. Within the blue box is indicated the putative binding site of Zur. The red box indicates the transcriptional start found by 5′RACE assays. (b) Sequence of the putative Zur binding site found in the hly II operon promoter. Bases recognized by Zur dimers are colored: green for conserved bases and red for the only base that is not conserved. A dashed line represents the symmetry axis. Below are depicted the positions of Zur binding sites in promoters of znuABC, zinT, rpmE29 and hlyII. Zur boxes were drawn to scale in respect of transcription start site. (c) Sequence of the 5′RACE assay using J96 total RNA samples grown in LB at 37 °C up to late log phase. The two bases identified as a transcriptional start are indicated with arrowheads. The N residue corresponds to a mix of A and C bases. (d) Electrophoretic mobility shift assay. Titration of a Cy5 labeled 50-bp hly II promoter fragment carrying the putative Zur binding site was carried out in the presence of excess salmon sperm DNA which serves as a non-specific competitor. Samples contains 60 pM DNA, plus 0, 15, 30, 50, 100, 150, 200, 300, 350, 900 pM Zur (calculated as dimer), respectively. Samples were resolved on a 10% polyacrylamide gel. Both gel and electrophoresis buffers contain 50 µM ZnSO4. Full-length gel image is shown in Fig. S9.

A transcriptional start for the hly II operon was previously proposed based on primer extension analyses on RNA samples from K12 strains carrying the hly II operon in a multicopy plasmid32. In our study, 5′-RACE with RNA samples from J96 was performed and a hly II operon transcription start was defined 9 nucleotides upstream of the previously described +1 position. This transcriptional start site is properly positioned to a putative promoter identified with the Neural Network Promoter Prediction software (Fig. 6a and c). Consequently, the putative Zur binding site is located at positions −25 to −6. Zur binding would overlap the −10 sequence, blocking the binding of RNA polymerase and repressing hly II transcription. The relative position of the putative Zur binding site found in the hly II operon and other genes of the E. coli Zur regulon was compared after searching the Zur consensus sequence described31 within the upstream regions of Zur-regulated genes9. The relative location of the putative Zur binding site in the hly II operon turned out to resemble the position of other members of the Zur regulon (Fig. 6b). For instance, the location of the Zur box in znuC and zinT is −22 to −3 and −23 to −4, respectively.

The ability of Zur to bind to the hly II promoter sequences in vitro was assessed using EMSA. The Zur protein used in this assay is derived from the E. coli strain MG1655, which shares 97.7% identity and 100% similarity with the Zur protein from J96. The results clearly demonstrate that Zur binds the hly II promoter in vitro (Fig. 6d). Remarkably, E. coli Zur binds to the hly II operon even more tightly than it does to the E. coli MG1655 Zur promoter region for the L31p promoter (0.025 ± 0.01 × 10−18 M2), which corresponds to the highest affinity of any of the operator sites evaluated31. While the binding is too tight to calculate a reliable dissociation constant under these experimental conditions, the Zur concentration at half maximal binding (100 nM Zur dimer) allow us to estimate an upper limit for this dissociation constant, i.e. <0.02 × 10−18 M2. Together with the in vivo studies on gene expression, these data reveal that Zur likely represses transcription of the hly II operon directly and confirm that the hly II operon is part of the Zur regulon in the UPEC strain J96. Interestingly, the putative Zur binding site was also found in the hly I operon from the UPEC strain 536 that is equivalent to hly II from J96. In 536 two mismatches from the consensus sequence were found: the mismatch already found in J96 hly II and a second base which does not directly interact with Zur (in position 13, a G instead of A or T is found). The upstream intergenic sequence of the hly I operon of J96 was also analyzed for a Zur binding site and, as expected, none was found. No Zur binding sites were found in upstream intergenic regions of hly operons from other UPEC isolates such as CFT073, UTI89 and F11. Pairwise alignments showed that these operons and their promoters are J96 hly I -like. Accordingly, the Δzur mutation in CFT073 does not cause an increase of HlyA production and hemolysis after infection of blood cells (Fig. S4).


The presence of two hlyCABD operons in the UPEC isolates J96 and 536, with more than 7 Kb DNA sequence sharing 99% identity, is intriguing considering that the presence of large homologous DNA sequences in a chromosome may cause genome instability and result in detrimental effects on bacterial fitness. Interestingly, the sequences upstream of the hlyC gene from both operons differ greatly, indicating that their regulatory sequences are unrelated and suggesting the existence of different mechanisms of regulation. Indeed, in this report we demonstrate that the hly II operon is silenced by the Zur regulator allowing expression only under zinc limiting conditions. In contrast, the operon hly I does not respond either to zinc or this regulator (Zur). Interestingly, most hlyCABD operons from human isolates described in databases showed homology to the Zur-insensitive operon hly I , whereas the hly II operon was only detected in two pyelonephritis isolates, 536 and J96, and in the environmental isolate MRE600. Recent genomic and phylogenetic studies revealed that MRE600 is an E. coli strain with distinctive genomic properties and more similar to Shigella than to other E. coli strains33.

One may hypothesize that expressing hemolysin under a wide variety of environmental conditions, including zinc limitation, may be beneficial to ensure success during the process of host colonization. In this scenario, the versatility provided by having two operons that respond to different conditions may constitute an adaptive advantage that outweighs the detrimental effect in fitness caused by genome instability due to the coexistence of large and highly homologous DNA sequences.

Previous studies suggest that zinc may play a relevant role during host colonization since zinc uptake systems are important for fitness in different pathogens, including UPEC6,34. However, the exact role of the Zur protein in the control of virulence factors has not yet been elucidated35. In S. aureus, Zur does not have an apparent role in pathogenicity, as concluded from assays using an in vivo infection model36. In M. tuberculosis and S. suis, Zur regulates genes coding for proteins belonging to the early secretory antigen target and metalloproteases, respectively, although the role of those proteins in virulence is unclear37,38. In A. baumannii, the zur mutant exhibits a defect in dissemination in a pneumonia mouse model, and RNA-seq assays showed that several genes encoding secreted proteins and putative virulence factors were upregulated in the mutant strain24. Our study is the first description of a direct Zur-mediated regulation of the expression of a virulence factor, UPEC’s α-hemolysin. More precisely, Zur represses the transcriptional expression of the hly II operon of J96, which consequently is only expressed under zinc limiting conditions. This finding raises thought-provoking questions. Is α-hemolysin expression a mechanism used by the bacterium to release or mobilize zinc from cells? If so, this may facilitate growth of bacterial pathogens in spite of host-induced zinc limitation. In this scenario, hly II expression would be acting as a bacterial factor involved in zinc homeostasis. Is the response of the J96 hly II operon to zinc, and therefore the acquisition of the Zur box, required for proper sensing of specific environments? If so, the presence of hly II may facilitate efficient colonization of sites within the host.

As exemplified by iron, metal limitation is a common situation during host-pathogen interactions1. Zinc concentration in most human tissues is extremely low39. Within the cytosol of human cells available zinc is particularly scarce, due to its sequestration by metallothioneins40. Furthermore, during infection phagocytes and epithelial cells express other zinc-chelating proteins, such as calprotectin41,42,43. In the case of UPEC, which invades the urinary tract, it inevitably faces zinc-limiting conditions since zinc concentration in human urine was reported to range between 0.17 and 0.5 ppm (2.6 to 7.6 µM) in healthy subjects, being one of the human corporal fluids with lowest zinc concentration reported39,44,45. Furthermore, UPEC probably encounters zinc starvation during intracellular growth, where bioavailable zinc is limited due to sequestration by host proteins like metallothioneins.

On the other hand, zinc concentration in the intestine, the reservoir of UPEC, is considerably high, due to the predominant fecal excretion of this metal46. One may speculate that during intestinal transit hly II expression would be repressed by Zur, and therefore very little HlyA would be produced from this operon. Interestingly, during acute gut inflammation, calprotectin released by neutrophils sequesters zinc and, during this zinc-limiting conditions, Salmonella enterica Typhimurium grows better than gut commensal bacteria due to increased expression of the Zur-regulated ZnuABC transporter3. Moreover, anomalously high expression of hlyA by the UPEC isolate 536 in the intestine has been detected during active ulcerative colitis, which produces acute inflammation47. Therefore, it is reasonable to hypothesize that intestinal zinc limitation due to inflammation could promote the production of HlyA by UPEC strains residing in the gut and carrying hemolytic operons responsive to zinc, thus producing further inflammatory lesions in ulcerative colitis. A recent report described zinc treatment to be efficient against α-hemolysin-induced intestinal leakage in mice colonized by the pyelonephritis isolate 53614. It is known that zinc is an important factor for intestinal barrier integrity48. Although the authors showed that zinc has a protective effect on α-hemolysin-mediated damage per se, our data indicate that zinc may have an additional protective effect by promoting downregulation of α-hemolysin expression from the 536 strain, which contains a homolog of the Zur-regulated operon here reported. Our study describes the direct involvement of Zur in the control of virulence expression and suggests that zinc limitation may play a pivotal signaling role during the infectious process.


Bacterial strains, plasmids and growth conditions

Bacterial strains used in this work, shown in Table 1, are all derived from the pathogenic isolates J96 and CFT073. All strains were grown routinely in LB (Lennox broth, tryptone 10 g l−1, yeast extract 5 g l−1 and NaCl 5 g l−1) at 37 °C with aeration. LB without NaCl and with 10 g l−1 of NaCl was used and denoted LB0 and LB10, respectively. In most experiments, bacterial cultures were grown up to an OD600 nm of 1.0, denoted late-log phase of growth. The zinc-free medium (M-LB) was prepared as indicated49. Briefly, LB medium was treated with 50 mg l−1 of chelating resin Chelex 100 (Bio-Rad) one hour at room temperature while stirring. After removing the resin by filtration (0.2 μm), trace elements were replenished by adding 1 μM FeCl3, 1 μM CaCl2, 20 μM MgCl2 and 1 ml l−1 SL-7 trace element solution (without zinc). Finally, 20 μM TPEN (N,N,N′,N′-Tetrakis(2-pyridylmethyl)ethylenediamine, Sigma-Aldrich) was added to further chelate zinc. Replenishment solutions were prepared out of concentrated stock solutions and sterilized by filtration using 0.2 μm filters when necessary. SL-7 trace element solution without zinc has the following composition: 10 ml 25% HCl, 1.5 g FeCl2·4H2O, 190 mg CoCl2·6H2O, 100 mg MnCl2·4H2O, 63 mg H3BO3, 36 mg Na2MoO4·2H2O, 24 mg NiCl2·6H2O, 17 mg CuCl2·2H2O and deionized water to a final volume of 1 L. In order to minimize contamination by zinc, all cultures with M-LB were performed in 5 ml culture medium using 50 ml conic centrifuge plastic tubes. Any other used material was also made of plastic and handled so as to avoid metal contamination. To monitor hemolytic phenotype Columbia Blood Agar plates (Scharlau) were used.

Table 1 Strains used in this work.

When needed, antibiotics were added to culture media at the indicated concentrations: kanamycin (50 μg ml−1), ampicillin (50 μg ml−1), chloramphenicol (25 μg ml−1) and gentamycin (10 μg ml−1). X-gal (5-bromo-4-chloro-3-indoyl-β-D-galactopyranoside) was added to the medium at 40 μg ml−1.

Genetic techniques

The primers used in this work are listed in Table S1 (supplementary material). The strain J96Δlac is a ΔlacZ derivative of J96 strain obtained as previously described50. The strain JFV16 (J96ΔII), carrying a hlyA deletion from codon 20 to 434 was constructed using the primers HlyA-P1 and HlyA-P2 and the method described by Datsenko and Wanner51. Strain JFV21 (J96ΔI), carrying a deletion from upstream of hlyC to the codon 422 of hlyA was constructed using the same methodology and the primers Hly1-P1 and Hly1-P2-2. Strain EV64 (J96ΔIΔII) was obtained using the same methodology and the primers Hly1-P1 and Hly1-P2-2 on the JFV16 strain. Similarly, zur mutants were generated using primers ZurP1 and ZurP2.2 in J96 and ZurP1.2 and ZurP2.1 in CFT073. The strain JFV3 carries a promoter less lacZ gene linked to a kanamycin resistance cassette inserted in the hlyA gene of the hly II operon. The lacZ-KmR cassette from plasmid pKG137 was inserted into the hlyA gene of JFV16 following the method described previously52. The zur gene of J96 together with the intergenic region located upstream of the zur ORF was PCR-amplified using the primers Zur-BamHI and Zur-EcoRI. The PCR-amplified fragment was cloned in pBR322 resulting the plasmid pBRzur.

SDS-PAGE and Western immunoblotting analyses

The standard SDS-PAGE procedure was used to monitor HlyA production. Gels were routinely stained with Coomassie blue. For immunoblotting, proteins were transferred to PVDF membranes and detected with the monoclonal anti-α-hemolysin H1053 and a horseradish peroxidase-conjugate antibody (Promega) using the ECL Plus Western Blotting Detection System (GE Healthcare). Gels were analyzed on a Chemidoc System (BioRad) equipped with the QuantityOne® Software.

β-Galactosidase assay

β-Galactosidase activity was monitored by the method described earlier54. Data shown are mean values and standard deviation of duplicate determinations from three independent experiments.

Assay of hemolytic activity

Quantitative hemolytic assay was performed essentially as previously described55. Briefly, a 10% defibrinated sheep blood suspension was prepared in 0.9% NaCl containing 10 mM CaCl2, centrifuged and resuspended in the same volume of the same solution. The wash step was repeated three times in order to eliminate debris from broken cells. Bacterial cultures were grown in LB10 at 37 °C to an OD600 nm of 1.0, centrifuged to discard supernatant and the bacterial pellet resuspended in the same volume of LB10. In 96-well microtiter plates 50 µl of blood suspension was mixed with an equal amount of a 1/125 dilution of the bacterial cell suspension, centrifuged (400 g, 10 min, 4 °C) and incubated for 60 min at 37 °C. Thereafter, 100 µl of ice-cold 0.9% NaCl was added and the microtiter plate was centrifuged (400 g, 10 min, 4 °C). A 100 µl aliquot of the supernatant was removed to another plate and the release of haemoglobin measured spectrophotometrically at 545 nm. In all plates non-infected wells were used as controls and the resulting OD545 nm from those controls was subtracted to the value obtained for the different samples. A bar shows the arithmetic mean of experimental results and the error bar indicates the standard deviation from three independent experiments. Control experiments using blood suspension prepared in 0.9% NaCl, in the absence of CaCl2, were performed. Consistent with the fact that the activity of hemolysin is calcium-dependent no hemoglobin release was detected. LB10 was used since regular LB (5 g/L NaCl) causes unspecific release of haemoglobin due to osmotic pressure alterations.

T24 cell culture assays

T24 bladder epithelial cells were maintained in RPMI supplemented with 10% heat-inactivated fetal bovine serum (FBS) and 1% penicillin-streptomycin. Bacterial cultures were grown in LB at 37 °C. Infection assays were performed in 24-well plates containing RPMI- 10% FBS where 10 µL of bacterial growth (OD600 nm of 0.5) were added to a monolayer of T24 cells. After infection, the cells were incubated at 37 °C, 5% CO2 for 2 h for microscopy analysis and for 3.5 h for measurements of cell detachment. The T24 monolayers were visualized after 2.5 h with an Axiovert 40 C inverted optical microscope (Carl Zeiss) and images were captured with EOS 1000D Canon camera at 25X increase. After 3.5 h infection, the cells were washed three times with ice-cold PBS, fixed in 10% formalin for 15 min at room temperature and stained in 0.1% Crystal Violet, 0.2% ethanol for 10 min at room temperature. After 2 washes with water, the cells were allowed to dry at room temperature and then lysed in 2% sodium dodecyl sulphate (SDS) for 30 min. The absorbance was quantified by spectrophotometry at 590 nm as an indicator of crystal violet staining. The data is given as percentage of attached cells. For each experiment the OD590 nm of non-infected samples was given arbitrarily the value 100%. A bar shows the arithmetic mean of experimental results and the error bar indicates the standard deviation from three biological replicates.

Random mutagenesis with pBT20 plasmid

Mutagenesis experiments were performed using the mariner-based transposon system carried on plasmid pBT2056. Bacterial suspensions of the donor (E. coli S17-λpir containing pBT20) and the recipient (JFV3) were recovered from overnight plates and resuspended in LB. These suspensions were adjusted to OD600 nm of 40 and 20, respectively, and mixed in a 1:1 ratio. Aliquots of 50 μl were spotted on a LB agar plate and incubated at 37 °C for 6 h. The mating mixtures were subsequently recovered in LB and cultured on LB agar plates containing kanamycin, gentamicin, and X-gal at 37 °C. Clones depicting darker blue color were selected, and hly II transcriptional expression was monitored by β-galactosidase quantification. Clone #13 genomic DNA was extracted using the Blood & Cell Culture DNA Midi kit (Qiagen) with the Genome DNA Buffer Set (Qiagen) and sequenced using the primer 526.

5′RACE assay

The 5′ end of the hly II operon transcript was determined using the 5′ RACE System for Rapid Amplification of cDNA Ends (Invitrogen). Total RNA was isolated from cultures of the J96 strain grown in LB at 37 °C up to an OD600 nm of 1.0. Retrotranscription was done using the oligo hlyIIBamIII, specific for the hly II operon. Next, a polyC tail was added to the 3′ end of the cDNA by using terminal deoxynucleotidyl transferase. Two rounds of PCR amplification were performed using specific primers for the hly II operon, hlyII-GSP2 and hlyII-GSP3, and primers provided by the commercial kit. The final PCR product was isolated and sequenced.

Electrophoretic Mobility Shift Assay

Zur binding to the Zur box of the J96 hly II operon was assessed as previously reported31. A fluorescence-labeled 50-bp fragment of the hly II promoter containing the putative Zur binding site was prepared by annealing two single strand DNA oligos. An oligo with a 5′ end Cy5 label (5′-/5Cy5/TCTTTATTTATTGTTTGTGTTATGTTATAACATATAAAAGAGTATTGTTT-3′) and its reversed complement sequence with no labels (5′-AAACAATACTCTTTTATATGTTATAACATAACACAAACAATAAATAAAGA-3′) were ordered from Integrated DNA Technologies (IDT). To make double stranded DNA, oligos were dissolved in the annealing buffer (10 mM Tris, 1 mM EDTA, 50 mM NaCl, pH 7.5), incubated at 95 oC for 5 min and slowly cooled to room temperature. 60 pM of DNA and various concentrations of the wild-type Zur protein (from E. coli MG1655) was mixed in the binding buffer (10 mM Tris, 10 mM NaCl, pH 8.0) containing 2 mM MgCl2, 1 mM CaCl2, 166 mM KCl, 100 mM L-potassium glutamic acid, 100 µg/mL bovine serum albumin (BSA), 2 µg/mL sonicated salmon sperm DNA, 5 mM DTT, 50 µM ZnSO4, 5% glycerol. DNA-protein mixtures were incubated at room temperature shielded from light for 30 minutes. The purity of the Zur protein used is shown in Fig. S5. In all Zur/DNA binding assays, protein samples were equilibrated with operator DNA with addition of excess non-specific competitor DNA (i.e. salmon sperm DNA). This allows direct monitoring of specific protein-DNA interactions. Samples were then resolved in a 10% polyacrylamide (37.5:1 acrylamide:bisacrylamide) gel. Both gel and electrophoresis buffers contain 89 mM Tris (pH 8.0), 89 mM boric acid and 50 µM ZnSO4. Gels were run at 10 V/cm for 60–70 minutes and visualized by Typhoon 9400 imager (GE Healthcare).

Statistical analysis

Analysis was carried out using R software. Unpaired t tests with p-values adjusted by Bonferroni’s method for multiple comparisons were used to make comparisons between two groups from a data set formed by several groups (i.e. cell detachment and cytolysis data). One-way analysis of variance (ANOVA) with Tukey’s multiple comparisons test was used for comparison of a data set formed by more than two groups (i.e. complementation assay). Two-way ANOVA was used to compare a data set with two variables (i.e. hlyII expression in several genotypes under different zinc concentrations). A value of P < 0.05 was considered statistically significant.

Data availability

All data generated or analyzed during this study are included in this published article (and its Supplementary Information files).

Additional information

Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.


  1. 1.

    Porcheron, G. & Dozois, C. M. Interplay between iron homeostasis and virulence: Fur and RyhB as major regulators of bacterial pathogenicity. Vet. Microbiol. 179, 2–14 (2015).

  2. 2.

    Wen, Y.-T. et al. Differential secretomics of Streptococcus pyogenes reveals a novel peroxide regulator (PerR)-regulated extracellular virulence factor mitogen factor 3 (MF3). Mol. Cell. Proteomics 10(M110), 007013 (2011).

  3. 3.

    Liu, J. Z. et al. Zinc sequestration by the neutrophil protein calprotectin enhances Salmonella growth in the inflamed gut. Cell Host Microbe 11, 227–239 (2012).

  4. 4.

    Ma, L., Terwilliger, A. & Maresso, A. W. Iron and zinc exploitation during bacterial pathogenesis. Metallomics 7, 1541–1554 (2015).

  5. 5.

    Hantke, K. Bacterial zinc uptake and regulators. Curr. Opin. Microbiol. 8, 196–202 (2005).

  6. 6.

    Palmer, L. D. & Skaar, E. P. Transition Metals and Virulence in Bacteria. Annu. Rev. Genet. 50, 67–91 (2016).

  7. 7.

    McDevitt, C. A. et al. A molecular mechanism for bacterial susceptibility to zinc. PLoS Pathog. 7, e1002357 (2011).

  8. 8.

    Patzer, S. I. & Hantke, K. The Zinc-responsive Regulator Zur and Its Control of the znu Gene Cluster Encoding the ZnuABC Zinc Uptake System in Escherichia coli. J. Biol. Chem. 275, 24321–24332 (2000).

  9. 9.

    Panina, E. M., Mironov, A. A. & Gelfand, M. S. Comparative genomics of bacterial zinc regulons: enhanced ion transport, pathogenesis, and rearrangement of ribosomal proteins. Proc. Natl. Acad. Sci. USA 100, 9912–9917 (2003).

  10. 10.

    Outten, C. E. & O’Halloran, T. V. Femtomolar Sensitivity of Metalloregulatory Proteins Controlling Zinc Homeostasis. Science (80-.). 292, 2488–2492 (2001).

  11. 11.

    Terlizzi, M. E., Gribaudo, G. & Maffei, M. E. UroPathogenic Escherichia coli (UPEC) Infections: Virulence Factors, Bladder Responses, Antibiotic, and Non-antibiotic Antimicrobial Strategies. Front. Microbiol. 8 (2017).

  12. 12.

    Ristow, L. C. & Welch, R. A. Hemolysin of uropathogenic Escherichia coli: A cloak or a dagger? Biochim. Biophys. Acta 1858, 538–545 (2016).

  13. 13.

    Mobley, H. L. et al. Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains. Infect Immun 58, 1281–1289 (1990).

  14. 14.

    Wiegand, S. et al. Zinc treatment is efficient against Escherichia coli α-haemolysin-induced intestinal leakage in mice. Sci. Rep. 7, 45649 (2017).

  15. 15.

    Welch, R. A. Pore-forming cytolysins of gram-negative bacteria. Mol Microbiol 5, 521–528 (1991).

  16. 16.

    Stanley, P., Koronakis, V. & Hughes, C. Acylation of Escherichia coli hemolysin: a unique protein lipidation mechanism underlying toxin function. Microbiol Mol Biol Rev 62, 309–333 (1998).

  17. 17.

    Thanabalu, T., Koronakis, E., Hughes, C. & Koronakis, V. Substrate-induced assembly of a contiguous channel for protein export from E.coli: reversible bridging of an inner-membrane translocase to an outer membrane exit pore. Embo J 17, 6487–6496 (1998).

  18. 18.

    Nagy, G. et al. Loss of regulatory protein RfaH attenuates virulence of uropathogenic Escherichia coli. Infect Immun 70, 4406–4413 (2002).

  19. 19.

    Nagamatsu, K. et al. Dysregulation of Escherichia coli α-hemolysin expression alters the course of acute and persistent urinary tract infection. Proc. Natl. Acad. Sci. USA 112, 871–880 (2015).

  20. 20.

    Nieto, J. M. et al. Expression of the hemolysin operon in Escherichia coli is modulated by a nucleoid-protein complex that includes the proteins Hha and H-NS. Mol Gen Genet 263, 349–358 (2000).

  21. 21.

    Mourino, M. et al. Environmental regulation of alpha-haemolysin expression in Escherichia coli. Microb Pathog 16, 249–259 (1994).

  22. 22.

    Dobrindt, U. et al. Toxin genes on pathogenicity islands: impact for microbial evolution. Int. J. Med. Microbiol. 290, 307–311 (2000).

  23. 23.

    Nagy, G. et al. Both alpha-haemolysin determinants contribute to full virulence of uropathogenic Escherichia coli strain 536. Microbes Infect. 8, 2006–2012 (2006).

  24. 24.

    Mortensen, B. L., Rathi, S., Chazin, W. J. & Skaar, E. P. Acinetobacter baumannii Response to Host-Mediated Zinc Limitation Requires the Transcriptional Regulator Zur. J. Bacteriol. 196, 2616–2626 (2014).

  25. 25.

    Welch, R. A., Hull, R. & Falkow, S. Molecular cloning and physical characterization of a chromosomal hemolysin from Escherichia coli. Infect. Immun. 42, 178–186 (1983).

  26. 26.

    Welch, R. A., Dellinger, E. P., Minshew, B. & Falkow, S. Haemolysin contributes to virulence of extra-intestinal E. coli infections. Nature 294, 665–667 (1981).

  27. 27.

    Balsalobre, C. et al. Release of the type I secreted alpha-haemolysin via outer membrane vesicles from Escherichia coli. Mol Microbiol 59, 99–112 (2006).

  28. 28.

    Patzer, S. I. & Hantke, K. The ZnuABC high-affinity zinc uptake system and its regulator Zur in Escherichia coli. Mol. Microbiol. 28, 1199–1210 (1998).

  29. 29.

    Skals, M., Jorgensen, N. R., Leipziger, J. & Praetorius, H. A. Alpha-hemolysin from Escherichia coli uses endogenous amplification through P2X receptor activation to induce hemolysis. Proc. Natl. Acad. Sci. USA 106, 4030–4035 (2009).

  30. 30.

    Dhakal, B. K. & Mulvey, M. A. The UPEC pore-forming toxin α-hemolysin triggers proteolysis of host proteins to disrupt cell adhesion, inflammatory, and survival pathways. Cell Host Microbe 11, 58–69 (2012).

  31. 31.

    Gilston, B. A. et al. Structural and Mechanistic Basis of Zinc Regulation Across the E. coli Zur Regulon. PLoS Biol. 12, e1001987 (2014).

  32. 32.

    Welch, R. A. & Pellett, S. Transcriptional organization of the Escherichia coli hemolysin genes. J. Bacteriol. 170, 1622–1630 (1988).

  33. 33.

    Kurylo, C. M. et al. Genome Sequence and Analysis of Escherichia coli MRE600, a Colicinogenic, Nonmotile Strain that Lacks RNase I and the Type I Methyltransferase, EcoKI. Genome Biol. Evol. 8, 742–752 (2016).

  34. 34.

    Warner, D. M. & Levy, S. B. SoxS Increases the Expression of the Zinc Uptake System ZnuACB in an Escherichia coli Murine Pyelonephritis Model. J. Bacteriol. 194, 1177–1185 (2012).

  35. 35.

    Somerville, G. A. & Proctor, R. A. At the crossroads of bacterial metabolism and virulence factor synthesis in Staphylococci. Microbiol. Mol. Biol. Rev. 73, 233–248 (2009).

  36. 36.

    Lindsay, J. A. & Foster, S. J. zur: a Zn(2+)-responsive regulatory element of Staphylococcus aureus. Microbiology 147, 1259–1266 (2001).

  37. 37.

    Maciag, A. et al. Global Analysis of the Mycobacterium tuberculosis Zur (FurB) Regulon. J. Bacteriol. 189, 730–740 (2007).

  38. 38.

    Feng, Y. et al. Functional definition and global regulation of Zur, a zinc uptake regulator in a Streptococcus suis serotype 2 strain causing streptococcal toxic shock syndrome. J. Bacteriol. 190, 7567–7578 (2008).

  39. 39.

    Zalewski, P. et al. Use of a zinc fluorophore to measure labile pools of zinc in body fluids and cell-conditioned media. Biotechniques 40, 509–520 (2006).

  40. 40.

    Jesse, H. E., Roberts, I. S. & Cavet, J. S. Metal Ion Homeostasis in Listeria monocytogenes and Importance in Host–Pathogen Interactions. Adv. Bact. Pathog. Biol. 65, 83–123 (2014).

  41. 41.

    Becker, K. W. & Skaar, E. P. Metal limitation and toxicity at the interface between host and pathogen. FEMS Microbiol. Rev. 38, 1235–1249 (2014).

  42. 42.

    Nakashige, T. G. et al. The Hexahistidine Motif of Host-Defense Protein Human Calprotectin Contributes to Zinc Withholding and Its Functional Versatility. J. Am. Chem. Soc. 138, 12243–12251 (2016).

  43. 43.

    Corbin, B. D. et al. Metal Chelation and Inhibition of Bacterial Growth in Tissue Abscesses. Science (80-.). 319, 962–965 (2008).

  44. 44.

    Razmandeh, R., Nasli-esfahani, E., Heydarpour, R., Faridbod, F. & Ganjali, M. R. Association of Zinc, Copper and Magnesium with bone mineral density in Iranian postmenopausal women – a case control study. J. Diabetes Metab. Disord. 13, 1–6 (2014).

  45. 45.

    Pfrimer, K. et al. Impact of aging on urinary excretion of iron and zinc. Nutr. Metab. Insights 7, 47–50 (2014).

  46. 46.

    Geissler, C. & Powers, H. J. Human nutrition. (Churchill Livingstone, 2011).

  47. 47.

    Bücker, R. et al. α-Haemolysin of Escherichia coli in IBD: a potentiator of inflammatory activity in the colon. Gut 63, 1893–1901 (2014).

  48. 48.

    Miyoshi, Y., Tanabe, S. & Suzuki, T. Cellular zinc is required for intestinal epithelial barrier maintenance via the regulation of claudin-3 and occludin expression. Am. J. Physiol. - Gastrointest. Liver Physiol. 311, 105–116 (2016).

  49. 49.

    Ellison, M. L., Farrow, J. M., Parrish, W., Danell, A. S. & Pesci, E. C. The Transcriptional Regulator Np20 Is the Zinc Uptake Regulator in Pseudomonas aeruginosa. PLoS One 8, e75389 (2013).

  50. 50.

    Aberg, A., Shingler, V. & Balsalobre, C. Regulation of the fimB promoter: a case of differential regulation by ppGpp and DksA in vivo. Mol Microbiol 67, 1223–1241 (2008).

  51. 51.

    Datsenko, K. A. & Wanner, B. L. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci USA 97, 6640–6645 (2000).

  52. 52.

    Ellermeier, C. D., Janakiraman, A. & Slauch, J. M. Construction of targeted single copy lac fusions using lambda Red and FLP-mediated site-specific recombination in bacteria. Gene 290, 153–161 (2002).

  53. 53.

    Pellett, S., Boehm, D. F., Snyder, I. S., Rowe, G. & Welch, R. A. Characterization of monoclonal antibodies against the Escherichia coli hemolysin. Infect. Immun. 58, 822–827 (1990).

  54. 54.

    Miller, J. H. A short course in Bacterial Genetics- Laboratory Manual. New York: Cold Spring Harbor Laboratory Press. (1992).

  55. 55.

    Field, T. R., Layton, A. N., Bispham, J., Stevens, M. P. & Galyov, E. E. Identification of novel genes and pathways affecting Salmonella type III secretion system 1 using a contact-dependent hemolysis assay. J. Bacteriol. 190, 3393–3398 (2008).

  56. 56.

    Kulasekara, H. D. et al. A novel two-component system controls the expression of Pseudomonas aeruginosa fimbrial cup genes. Mol. Microbiol. 55, 368–380 (2004).

Download references


This work was supported by the Spanish Ministry of Economy and Competitiveness (grant AGL2013-45339-R, CB) (grant SAF2014-57856, A.F.V.), the Catalonian government (grant 2017SGR499, CB), the US National Institutes of Health (grants R01 GM038784, TVO). E.G. received a fellowship from the UB (APIF). We thank Dr. Cristina Madrid (Universitat de Barcelona) and Dr. Sandy Siepka (Northwestern University) for critical reading of the manuscript and fruitful discussions. We thank Northwestern University - the Keck Biophysics Facility for providing the Typhoon 9400 imager to scan the EMSA gels.

Author information


  1. Department of Genetics, Microbiology and Statistics, School of Biology, Universitat de Barcelona, Avda. Diagonal 643, Barcelona, 08028, Spain

    • Elsa Velasco
    • , Marianna Sanet
    • , Jorge Fernández-Vázquez
    • , Daniel Jové
    •  & Carlos Balsalobre
  2. Chemistry of Life Process Institute, and Department of Chemistry, Northwestern University, Evanston, Illinois, 60208-3113, United States of America

    • Suning Wang
    •  & Thomas V. O’Halloran
  3. Nuclear Receptor Group, Department of Cell Biology, Physiology and Immunology, School of Biology, Universitat de Barcelona, Avda. Diagonal 643, Barcelona, 08028, Spain

    • Estibaliz Glaría
    •  & Annabel F. Valledor


  1. Search for Elsa Velasco in:

  2. Search for Suning Wang in:

  3. Search for Marianna Sanet in:

  4. Search for Jorge Fernández-Vázquez in:

  5. Search for Daniel Jové in:

  6. Search for Estibaliz Glaría in:

  7. Search for Annabel F. Valledor in:

  8. Search for Thomas V. O’Halloran in:

  9. Search for Carlos Balsalobre in:


All authors conceived and designed the study. E.V., M.S., J.F.-V., S.W., D.J., E.G. and C.B. performed the investigations. C.B. and E.V. wrote the original draft of the manuscript text and prepared the figures. All authors reviewed the manuscript.

Competing Interests

The authors declare no competing interests.

Corresponding author

Correspondence to Carlos Balsalobre.

Electronic supplementary material

About this article

Publication history





Rights and permissions

Creative Commons BY

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.